Peer Review reports
From: GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer
| Original Submission | ||
|---|---|---|
| 9 Mar 2023 | Submitted | Original manuscript |
| 20 Mar 2023 | Author responded | Author comments - Qiang Zhan |
| 21 Mar 2023 | Author responded | Author comments - Qiang Zhan |
| Resubmission - Version 2 | ||
| 20 Mar 2023 | Submitted | Manuscript version 2 |
| 21 May 2023 | Reviewed | Reviewer Report |
| 12 Jun 2023 | Reviewed | Reviewer Report |
| 1 Aug 2023 | Author responded | Author comments - Qiang Zhan |
| Resubmission - Version 3 | ||
| 1 Aug 2023 | Submitted | Manuscript version 3 |
| 9 Aug 2023 | Author responded | Author comments - Qiang Zhan |
| Resubmission - Version 4 | ||
| 9 Aug 2023 | Submitted | Manuscript version 4 |
| 12 Aug 2023 | Reviewed | Reviewer Report |
| 13 Aug 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 17 Aug 2023 | Editorially accepted | |
| 2 Oct 2023 | Article published | 10.1186/s12885-023-11308-0 |
You can find further information about peer review here.